BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21338720)

  • 21. Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial.
    Evangelista MT; Casintahan MF; Villafuerte LL
    Br J Dermatol; 2014 May; 170(5):1151-7. PubMed ID: 24506834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized study of 980 nm diode laser-assisted venous ulcer healing on 34 patients.
    Leclère FM; Puechguiral IR; Rotteleur G; Thomas P; Mordon SR
    Wound Repair Regen; 2010; 18(6):580-5. PubMed ID: 20958856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled, multicenter study.
    Beckert S; Warnecke J; Zelenkova H; Kovnerystyy O; Stege H; Cholcha W; Königsrainer A; Coerper S
    J Vasc Surg; 2006 Jan; 43(1):94-100. PubMed ID: 16414395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of topical phenytoin on burn wound healing in rats.
    Meena K; Mohan AV; Sharath B; Somayaji SN; Bairy KL
    Indian J Exp Biol; 2011 Jan; 49(1):56-9. PubMed ID: 21365997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial.
    Shaw J; Hughes CM; Lagan KM; Stevenson MR; Irwin CR; Bell PM
    Diabet Med; 2011 Oct; 28(10):1154-7. PubMed ID: 21480976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
    Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
    Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency.
    Roztocil K; Stvrtinová V; Strejcek J
    Int Angiol; 2003 Mar; 22(1):24-31. PubMed ID: 12771852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical phenytoin solution for treating pressure ulcers: a prospective, randomized, double-blind clinical trial.
    Subbanna PK; Margaret Shanti FX; George J; Tharion G; Neelakantan N; Durai S; Chandy SJ; Mathew BS; Suresh R
    Spinal Cord; 2007 Nov; 45(11):739-43. PubMed ID: 17279096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds.
    Carneiro PM; Rwanyuma LR; Mkony CA
    Cent Afr J Med; 2002; 48(9-10):105-8. PubMed ID: 14562531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, controlled study of innovative spray formulation containing ozonated oil and α-bisabolol in the topical treatment of chronic venous leg ulcers.
    Solovăstru LG; Stîncanu A; De Ascentii A; Capparé G; Mattana P; Vâţă D
    Adv Skin Wound Care; 2015 Sep; 28(9):406-9. PubMed ID: 26280699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693].
    Hollisaz MT; Khedmat H; Yari F
    BMC Dermatol; 2004 Dec; 4(1):18. PubMed ID: 15601464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers.
    Atri SC; Misra J; Bisht D; Misra K
    Surgery; 1990 Sep; 108(3):508-12. PubMed ID: 2396195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.
    De Sanctis MT; Belcaro G; Cesarone MR; Ippolito E; Nicolaides AN; Incandela L; Geroulakos G
    Angiology; 2002; 53 Suppl 1():S49-51. PubMed ID: 11865837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of Iloprost for the treatment of chronic venous ulcers of the lower limbs.
    Canciglia A; Mandolfino T; D'Alfonso M
    G Chir; 2011 Oct; 32(10):434-7. PubMed ID: 22018220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical phenytoin versus EUSOL in the treatment of non-malignant chronic leg ulcers.
    Carneiro PM; Nyawawa ET
    East Afr Med J; 2003 Mar; 80(3):124-9. PubMed ID: 12762426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into therapy by mathematical analysis: recalcitrant granulated improved more than sclerotic venous leg ulcers with amelogenin treatment.
    Renner R; Simon JC
    J Dermatol Sci; 2012 Jul; 67(1):15-9. PubMed ID: 22608215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of two different intermittent pneumatic compression cycle settings in the healing of venous ulcers: a randomized trial.
    Nikolovska S; Arsovski A; Damevska K; Gocev G; Pavlova L
    Med Sci Monit; 2005 Jul; 11(7):CR337-43. PubMed ID: 15990691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects.
    Scheinfeld N
    Dermatol Online J; 2003 Aug; 9(3):6. PubMed ID: 12952753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.